Health Care [ 9/12 ] | Biotechnology [ 61/74 ]
NASDAQ | Common Stock
Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States.
Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 31, 25 | -3.15 Decreased by -279.52% | -5.42 Increased by +41.94% |
| Mar 26, 25 | -6.65 Decreased by -798.65% | -9.80 Increased by +32.14% |
| Nov 14, 24 | -19.60 Decreased by -2.66 K% | -5.95 Decreased by -229.41% |
| Aug 12, 24 | -0.86 Decreased by -13.16% | -0.83 Decreased by -3.61% |
| May 13, 24 | -0.83 Decreased by -23.88% | -0.76 Decreased by -9.21% |
| Mar 25, 24 | -0.74 Decreased by -21.31% | -0.71 Decreased by -4.23% |
| Nov 13, 23 | -0.71 Decreased by -26.79% | -0.69 Decreased by -2.90% |
| Aug 14, 23 | -0.76 Decreased by -55.10% | -0.70 Decreased by -8.57% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | N/A Decreased by N/A% | -2.52 M Increased by +89.14% | - - |
| Dec 31, 24 | 0.00 Decreased by -100.00% | -5.43 M Increased by +73.40% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -16.24 M Increased by +17.00% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -24.77 M Decreased by -30.22% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -23.19 M Decreased by -50.55% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 136.00 K Increased by +N/A% | -20.41 M Decreased by -35.89% | Decreased by -15.01 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -19.56 M Decreased by -50.21% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -19.02 M Decreased by -61.68% | Decreased by N/A% Decreased by N/A% |